Skip to content
OpenCapital
Get started

Iovance Biotherapeutics, Inc. IOVA Quick ratio

Quick ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.3×+0.1×
Gilead Sciences logo
Gilead SciencesGILD
1.7×+0.5×
Immunome logo
ImmunomeIMNM
21.7×+11.2×
Nuvation Bio logo
Nuvation BioNUVB
7.2×-1.8×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
6.4×+4.3×
Immunovant, Inc. logo
Immunovant, Inc.IMVT
9.1×-2.1×

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%
EPS (diluted)-$0.19+47.2%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Market cap$1.98B+32.4%
Enterprise value$1.83B+33.2%
P/S6.9×-0.1×

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Iovance Biotherapeutics, Inc.’s reported figures.

quick assets/total current liabilities=3.2×

Based on the most recent quarter.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s quick ratio?
Iovance Biotherapeutics, Inc. (IOVA) reported quick ratio of 3.2× in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s quick ratio changed year-over-year?
Iovance Biotherapeutics, Inc.'s quick ratio decreased by 13.5% year-over-year, from 3.6× to 3.2×.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s quick ratio has grown at a -24.6% compound annual growth rate (CAGR), from 11.6× to 2.8×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.